Literature DB >> 9703334

Altered activities of transcription factors and their related gene expression in cardiac tissues of diabetic rats.

Y Nishio1, A Kashiwagi, H Taki, K Shinozaki, Y Maeno, H Kojima, H Maegawa, M Haneda, H Hidaka, H Yasuda, K Horiike, R Kikkawa.   

Abstract

Gene regulation in the cardiovascular tissues of diabetic subjects has been reported to be altered. To examine abnormal activities in transcription factors as a possible cause of this altered gene regulation, we studied the activity of two redox-sensitive transcription factors--nuclear factor-kappaB (NF-kappaB) and activating protein-1 (AP-1)--and the change in the mRNA content of heme oxygenase-1, which is regulated by these transcription factors in the cardiac tissues of rats with streptozotocin-induced diabetes. Increased activity of NF-kappaB and AP-1 but not nuclear transcription-activating factor, as determined by an electrophoretic mobility shift assay, was found in the hearts of 4-week diabetic rats. Glycemic control by a subcutaneous injection of insulin prevented these diabetes-induced changes in transcription factor activity. In accordance with these changes, the mRNA content of heme oxygenase-1 was increased fourfold in 4-week diabetic rats and threefold in 24-week diabetic rats as compared with control rats (P < 0.01 and P < 0.05, respectively). Insulin treatment also consistently prevented changes in the mRNA content of heme oxygenase-1. The oral administration of an antioxidant, probucol, to these diabetic rats partially prevented the elevation of the activity of both NF-kappaB and AP-1, and normalized the mRNA content of heme oxygenase-1 without producing any change in the plasma glucose concentration. These results suggest that elevated oxidative stress is involved in the activation of the transcription factors NF-kappaB and AP-1 in the cardiac tissues of diabetic rats, and that these abnormal activities of transcription factors could be associated with the altered gene regulation observed in the cardiovascular tissues of diabetic rats.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9703334     DOI: 10.2337/diab.47.8.1318

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  10 in total

1.  Alterations in the diabetic myocardial proteome coupled with increased myocardial oxidative stress underlies diabetic cardiomyopathy.

Authors:  Milton Hamblin; David B Friedman; Salisha Hill; Richard M Caprioli; Holly M Smith; Michael F Hill
Journal:  J Mol Cell Cardiol       Date:  2007-01-10       Impact factor: 5.000

2.  A stress-responsive glyoxalase I from the parasitic nematode Onchocerca volvulus.

Authors:  A Sommer; P Fischer; K Krause; K Boettcher; P M Brophy; R D Walter; E Liebau
Journal:  Biochem J       Date:  2001-02-01       Impact factor: 3.857

3.  Glycosylated human oxyhaemoglobin activates nuclear factor-kappaB and activator protein-1 in cultured human aortic smooth muscle.

Authors:  Concepcion Peiro; Nuria Matesanz; Julian Nevado; Nuria Lafuente; Elena Cercas; Veronica Azcutia; Susana Vallejo; Leocadio Rodriguez-Manas; Carlos F Sanchez-Ferrer
Journal:  Br J Pharmacol       Date:  2003-09-22       Impact factor: 8.739

4.  Dietary supplementation with vitamin E ameliorates cardiac failure in type I diabetic cardiomyopathy by suppressing myocardial generation of 8-iso-prostaglandin F2alpha and oxidized glutathione.

Authors:  Milton Hamblin; Holly M Smith; Michael F Hill
Journal:  J Card Fail       Date:  2007-12       Impact factor: 5.712

5.  The effects of acute acetaminophen toxicity on hepatic mRNA expression of SOD, CAT, GSH-Px, and levels of peroxynitrite, nitric oxide, reduced glutathione, and malondialdehyde in rabbit.

Authors:  Yilmaz Cigremis; Huseyin Turel; Kevser Adiguzel; Muslum Akgoz; Asim Kart; Musa Karaman; Hasan Ozen
Journal:  Mol Cell Biochem       Date:  2008-11-28       Impact factor: 3.396

6.  Diabetic Cardiomyopathy in OVE26 Mice Shows Mitochondrial ROS Production and Divergence Between In Vivo and In Vitro Contractility.

Authors:  Ye Song; Yibo Du; Sumanth D Prabhu; Paul N Epstein
Journal:  Rev Diabet Stud       Date:  2007-11-10

7.  Emerging role for antioxidant therapy in protection against diabetic cardiac complications: experimental and clinical evidence for utilization of classic and new antioxidants.

Authors:  Michael F Hill
Journal:  Curr Cardiol Rev       Date:  2008-11

8.  Multiple antioxidants improve cardiac complications and inhibit cardiac cell death in streptozotocin-induced diabetic rats.

Authors:  Santosh Kumar; Sahdeo Prasad; Sandhya L Sitasawad
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240

9.  Immunomodulatory effects of thalidomide in an experimental brain death liver donor model.

Authors:  Alexandre Chagas Santana; Wellington Andraus; Filipe Miranda Oliveira Silva; Humberto Dellê; Rafael Pepineli; Edvaldo Leal de Moraes; Cristoforo Scavone; Larissa de Sá Lima; Sabrina Degaspari; Sergio Brasil; Davi Jorge Fontoura Solla; Liliane Moreira Ruiz; Karina Andrighetti de Oliveira-Braga; Natalia Aparecida Nepomuceno; Paulo Manuel Pêgo-Fernandes; Stefan Gunther Tullius; Eberval Gadelha Figueiredo
Journal:  Sci Rep       Date:  2021-09-28       Impact factor: 4.379

10.  The protective effects of S14G-humanin (HNG) against streptozotocin (STZ)-induced cardiac dysfunction.

Authors:  Xiaopan Chen; Chuan Yun; Hailong Zheng; Xu Chen; Qianfei Han; Hua Pan; Yang Wang; Jianghua Zhong
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.